BHRT vs traditional HRT: which should I ask for and where?

Short answer

• Start by asking a menopause-savvy clinician (board-certified OB‑GYN, endocrinologist or family physician with menopause training/NAMS certification) for a personalized plan.
• Prefer FDA‑approved “bioidentical” products when possible (estradiol products + micronized progesterone) because they have quality, dosing and safety data. Use compounded BHRT only when you and your clinician have a clear reason and you use an accredited compounding pharmacy.

What “BHRT” vs “traditional HRT” really means

• “Bioidentical” means the hormone molecule is chemically identical to human hormones (example: 17β‑estradiol, micronized progesterone). Some of these are available as FDA‑approved medicines.
• “Traditional HRT” often refers to FDA‑approved estrogen and progestin products (these include both bioidentical and non‑bioidentical molecules).
• “Compounded BHRT” is custom‑mixed by compounding pharmacies and is not FDA‑approved; it can be useful for unusual dosage forms or allergies but has more variability and less safety/efficacy data.

Evidence/safety highlights (quick)

• FDA‑approved estradiol (especially transdermal) and micronized progesterone (Prometrium) have the best-known safety/quality profiles. Transdermal estrogen may have lower VTE risk than some oral estrogens.
• Some synthetic progestins have different risk profiles than micronized progesterone.
• Compounded products lack the same testing and labeling requirements — they’re not necessarily safer.

What to ask your clinician

• “Based on my symptoms, age, medical history and risk factors, would I benefit from hormone therapy?”
• “Can we use FDA‑approved, bioidentical estradiol and micronized progesterone if appropriate (for example transdermal estradiol + Prometrium)?”
• “If you recommend a compounded formulation, which compounding pharmacy do you use and can you show me their quality/certification info (PCAB/USP compliance, batch testing/Certificate of Analysis)?”
• “What is the lowest effective dose, route (patch, gel, oral, vaginal), duration, and monitoring plan?”
• Ask about alternatives for specific symptoms (vaginal estrogen for local symptoms, nonhormonal options for hot flashes if HRT contraindicated).

Which specific medicines and brands to consider (FDA‑approved)

• Estradiol: Vivelle‑Dot, Climara, Alora (patches); Estrace (oral estradiol); Evamist (spray) — transdermal patches/gels are often preferred for lower clot risk.
• Vaginal estrogen for local symptoms: Vagifem, Estrace cream.
• Progesterone (bioidentical, FDA‑approved): Prometrium (micronized progesterone).
  These are preferable because they are manufactured under FDA standards and have clinical trial data.

If you’re considering compounded BHRT

• Only use it for specific, documented reasons (e.g., allergy to an excipient, unique dose/route not commercially available).
• Use a reputable, accredited compounding pharmacy (look for PCAB accreditation and USP <795>/<797> compliance). Examples of widely used compounding pharmacies in hormone care include Wedgewood Pharmacy (well known in transgender and hormone therapy circles) — but check current accreditation and reviews. Ask your clinician which pharmacy they trust and to provide quality documentation before you fill a compound.

Where to go / who to see

• In‑person: board‑certified OB‑GYN with menopause expertise, a reproductive endocrinologist or endocrinologist, or a family physician experienced in menopause. Use the North American Menopause Society (NAMS) clinician locator to find certified menopause practitioners. Major centers with menopause clinics: Mayo Clinic Menopause Clinic, Cleveland Clinic Menopause Center, Johns Hopkins Menopause Clinic.
• Telehealth: several women’s health-focused telemedicine services can manage menopause/HRT, but choose ones that connect you with credentialed clinicians and use accredited pharmacies. Examples of broader women’s telehealth platforms: Maven Clinic, Tia; for direct HRT services evaluate credentials and pharmacy partnerships closely.
• If you want in‑depth counseling, look for “menopause specialist” or “certified menopause practitioner” (NAMS).

What monitoring/testing to expect

• Review medical history and risk factors (breast/ovarian cancer history, thromboembolism, cardiovascular disease).
• Baseline: blood pressure, BMI, mammogram per age/screening history, and routine labs as indicated (lipids, glucose/HbA1c). Hormone blood levels are not routinely required to guide standard HRT dosing.
• Follow up to assess symptoms, side effects, and periodic screening (mammography, BP, metabolic labs) as recommended by your clinician.

Bottom line / recommended first step

• Ask a menopause‑trained clinician for an individualized plan and, if appropriate, request FDA‑approved bioidentical estradiol (prefer transdermal when clot risk is a concern) and micronized progesterone (Prometrium) before turning to compounded BHRT. If you do use a compounding pharmacy, insist on PCAB/USP accreditation and quality documentation.

If you want, tell me: age, main symptoms, major medical history (clotting, breast cancer, heart disease), and whether you prefer in‑person or telehealth — I can suggest the next specific step and help find a provider or clinic in your area.